Trial Profile
LEO 90100 in the Treatment of Psoriasis Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2021
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Betamethasone; Calcipotriol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 24 Mar 2015 Results presented at the 73rd Annual Meeting of the American Academy of Dermatology.
- 04 Sep 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Mar 2012 New trial record